An exciting moment for the lab as Dr. Sheila Singh presented the Innovation Hub alongside Professor Shitij Kapur, Vice-Chancellor & President of King’s, to His Majesty The King during the 300th anniversary celebrations of Guy’s Hospital. @KingsCollegeLon
https://t.co/JapovlDfvh
Dearest gentle reader, we are delighted to announce a new story from our lab published in @Nature describing how a meal's systemic metabolic changes are interpreted by your immune system to enhance adaptive immunity. A thread 1/ https://t.co/zACqCLxDMU
I am looking to nominate a recent Canadian PhD graduate (less than 2 years since graduation) for a Pet Trust PDF fellowship (starting salary is $70K per annum for 3 years).
The position provides opportunities for extensive collaboration with veterinary oncologists, basic scientists, and several opportunities to mentor graduate students in multiple collaborative labs.
New #JITC article: "Stem-like PD-1+TCF-1+ CD8+ T cells result from helpless priming and rely on CD4+ T-cell help to complete their cytotoxic effector differentiation" https://t.co/ZbhZS3aGFq
📣Researchers needed to evaluate Spring 2026 Project Grant applications. Our research ecosystem depends on all of us.
Say “YES” when asked to peer review.
Someone took the time to review your last grant. Now it’s your turn.
CIHR needs reviewers for the Spring 2026 Project Grant competition.
Say “YES” when asked.
📢DAVID EARNS AWARD!
🍏Canadian Nutrition Society
🏆Earle Willard McHenry Award
🏅For Distinguished Service in Nutrition!
🍾CONGRATULATIONS DAVID!👍
🎓Dr. David Ma, Prof. @UofG_HHNS!
💼Director, Guelph Family Health Study
🔗https://t.co/OFlRNbRhet @UofGResearch!
🏛️#UofG#Guelph
KRAS inhibitors have been used to treat pancreatic cancer, but can they PREVENT cancer from occurring altogether? In @ScienceMagazine from @PennCancer
Cancer interception with KRAS inhibitors in preclinical models of #PancreaticCancer
https://t.co/0m81twRXpN
We're proud to partner with @TheMarkFdn and leading philanthropic organizations to invest $4M in #glioblastoma research. Congrats to this exceptional group of awardees. We're honored to support their innovative work for patients facing this disease.
https://t.co/anZSzEZ7Px
Join us in Reykjavik, Iceland, to hear the latest breakthroughs in cancer immunology and immunotherapy—set against an unforgettable backdrop.
FOCIS goes North: Iceland Cancer Immunology Conference: https://t.co/cccBEd11ir
#CancerImmunology#immunotherapy
Michelle Monje, Benjamin Deneen, and Shawn Hervey-Jumper will discuss "The Neuroscience of Gliomas" in a plenary session at the AACR Special Conference on Brain Cancer (March 23-25, 2026; Philadelphia). Learn more:
https://t.co/kMBzu6YYUm
#AACRbrain26@michelle_monje
Are you interested in applying for CIHR funding?
See all current funding opportunities: https://t.co/dIvY6SMzlm
Newly launched:
•ERDERA Joint Transnational Call 2026
•European Partnership for Brain Health
Thrilled to share our first iteration of IL-12–armored CAR T cells targeting tumor associated macrophages (TAM) to treat metastatic cancer. Led by the fantastic @jaimemateustique as a collaboration between @brown_lab1 and my lab @sinaiimmunology. https://t.co/PEaJ3VJF1d (1/4)
A new paper published in @SpringerNature by PhD student @sarah_worfolk in the Department of @OVCPathobiology, supervised by Dr. @samworkenhe, explores how dogs regulate cell death differently from humans and what this could mean for future therapies.🔗https://t.co/Lp2IyAHoHW